TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Kovai Medical Center & Ho
KOVAI

Kovai Medical Center & Ho Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 62/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹6,090.5

Change

-10.5 (-0.17%)

Open

₹6,101.0

Prev. Close

₹6,101.0

Day High

₹6,148.0

Day Low

₹6,063.0

Volume Analysis

Traded

3,285

Delivered

1,897

Delivery %

57.75%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •Strong return on equity (22.2%)
  • •Strong operating margin (22.0%)

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹6,223.0 ₹6,185.5 ₹6,138.0 ₹6,100.5 ₹6,053.0 ₹6,015.5 ₹5,968.0
Fibonacci ₹6,185.5 ₹6,153.03 ₹6,132.97 ₹6,100.5 ₹6,068.03 ₹6,047.97 ₹6,015.5
Camarilla ₹6,113.88 ₹6,106.08 ₹6,098.29 ₹6,100.5 ₹6,082.71 ₹6,074.92 ₹6,067.13

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-1.43%

1 Month

+0.96%

3 Months

+1.53%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹561.04

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

20.17%

Net margin 9.8% × asset turnover 0.98x × equity multiplier 2.1x

Company Overview

Sector

Healthcare

Market Cap

₹6,653 Cr

P/E (TTM)

115.0

ROE

22.2%

Book Value

₹264.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.

TopFund Analysis

Kovai Medical Center & Ho lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 62/100. The strongest factor is Risk & Volatility (89/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (22.2%); strong operating margin (22.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

62/100 — Average

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

76

Growth

79

Valuation

1

Cash Flow

68

Corporate Governance

66

Momentum

63

Institutional Ownership

34

Business Quality

84

Risk & Volatility

89

Liquidity

42

From Screener.in

  • +Company has a good return on equity (ROE) track record: 3 Years ROE 25.5%
  • +Company's median sales growth is 19.0% of last 10 years
  • −Stock is trading at 23.1 times its book value
  • −Company might be capitalizing the interest cost

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 21 Sep 21 Sep
Closure of Trading Window 19 Sep 19 Sep
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 27 Aug

KMCH submitted 40th AGM voting results for 26 August 2026; all resolutions passed.

Shareholder Meeting / Postal Ballot-Outcome of AGM 26 Aug

KMCH held its 40th AGM on 26 Aug 2026; approved dividend, financials, and director appointment.

Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Aug

We enclose herewith the copies of Newspaper Advertisement published in English and Tamil in the "Trinity mirror" and "Makkal Kural" respectively, with regard to the …

Source: BSE regulatory filings, via Screener.in.

Profit & Loss (Yearly)

  Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
Sales + 88 110 130 175 222 297 334 402 465 531 592
Expenses + 73 91 104 138 178 226 261 307 373 406 463
Operating Profit 15 19 26 37 44 71 73 95 92 125 129
OPM % 17.0% 17.0% 20.0% 21.0% 20.0% 24.0% 22.0% 24.0% 20.0% 24.0% 22.0%
Other Income + 1 1 2 1 1 3 5 7 8 6 8
Interest 3 4 5 11 17 27 24 20 17 15 13
Depreciation 5 4 5 7 13 16 16 22 21 24 34
Profit before tax 7 11 17 20 16 31 37 59 62 92 89
Tax % 41.0% 35.0% 33.0% 38.0% 26.0% 33.0% 36.0% 35.0% 35.0% 35.0% 35.0%
Net Profit + 4 7 12 12 12 20 24 39 41 60 58
EPS in Rs 4 7 11 11 11 19 22 35 37 55 53
Dividend Payout % 32.0% 19.0% 12.0% 11.0% 11.0% 8.0% 7.0% 4.0% 7.0% 5.0% 6.0%

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
Reserves 13 19 29 40 50 68 90 126 163 223 278
Borrowings + 38 70 108 192 228 209 184 163 158 125 202
Other Liabilities + 31 25 25 41 50 55 65 85 96 103 116
Total Liabilities 93 126 173 283 338 344 350 384 428 462 606
Fixed Assets + 62 69 106 193 295 285 282 285 342 358 444
CWIP 6 20 42 38 0 5 5 17 10 6 13
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets + 25 36 25 53 43 54 62 83 76 99 149
Total Assets 93 126 173 283 338 344 350 384 428 462 606
Equity Capital 11 11 11 11 11 11 11 11 11 11 11

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
Cash from Operating Activity + — 15 24 42 56 61 68 97 86 99 87
Cash from Investing Activity + — -23 -64 -97 -77 -9 -12 -80 -115 -83 -191
Cash from Financing Activity + — 27 31 71 17 -48 -52 -43 -24 -50 60
Net Cash Flow — 18 -9 16 -3 5 4 -26 -53 -34 -45
CFO/OP — 97 113 123 136 96 103 119 110 100 92
Free Cash Flow — -8 -41 -56 -21 51 53 60 15 63 -41

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 56.43% → 56.53%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 39.24% 39.24% 39.02% 38.91% 38.67% 38.46% 38.32% 37.65% 37.34% 37.43% 37.8% 37.98%
Promoters 56.43% 56.44% 56.47% 56.5% 56.51% 56.55% 56.55% 56.55% 56.52% 56.53% 56.53% 56.53%
FII 2.25% 2.24% 0.34% 0.32% 0.44% 0.55% 1.1% 1.27% 1.25% 1.31% 1.21% 1.25%
DII 2.09% 2.09% 4.18% 4.28% 4.37% 4.43% 4.03% 4.52% 4.89% 4.73% 4.47% 4.24%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Kovai Medical Center & Ho (this stock) 6,653 115.0 23.07 22.2%
Morepen Lab. Ltd 6,596 56.2 5.26 5.33%
Sun Pharma Adv.res.co.ltd 6,784 4.25 5.06 279.0%
Symbiotec Pharmalab Ltd 6,447 64.8 — 11.7%
Orchid Pharma Limited 6,377 353.0 3.55 1.49%
Nephrocare Health Serv L 7,005 82.3 6.28 8.83%
Senores Pharmaceuticals L 6,241 49.4 6.67 13.4%

Which Mutual Funds Hold Kovai Medical Center & Ho?

Frequently Asked Questions about Kovai Medical Center & Ho

Community Sentiment

What are other investors saying about Kovai Medical Center & Ho?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.